Table 1.
Pre-liver transplantation features in patients with and without AIH recurrence (n = 38)
| Clinical features | AIH recurrence, n = 3 | AIH no recurrence, n = 35 | Total, n = 38 |
|---|---|---|---|
| Age at diagnosis, median (min–max) | 30 (13–50) | 37 (6–71) | 33.5 (6–71) |
| Age at transplant, mean | 42.3 | 47.1 | 46.8 |
| Female sex, n (%) | 2 (83%) | 25 (71%) | 27 (71%) |
| Caucasian: non-Caucasian ratio | 3:0 | 28:7 | 31:7 |
| Concomitant autoimmune conditionsa | 2 (83%) | 7 (21%) | 9 (24%) |
| Associated IBD | 1 (33%) | 3 (9%) | 4 (10%) |
| Listing MELD, mean | 15.3 | 24.2 | 19.7 |
| Transplant MELD, mean | 16 | 25.7 | 24.9 |
| Interval from diagnosis to transplant (years), mean (SD) | 11.3 (±3.9) | 9.7 (±10.4) | 9.8 (±10.1) |
| Time on waiting list (days), mean (SD) | 126 (±35.5) | 137.2 (±263) | 136.3 (±253) |
AIH, Autoimmune hepatitis; IBD, Inflammatory Bowel Disease; MELD, Model for End-Stage Liver Disease score.
aType 1 diabetes, celiac disease and rheumatoid arthritis.